Daewoong pharmaceutical Co.,Ltd

KRX:069620.KS

128600 (KRW) • At close January 15, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.

202320222021202020192018201720162015201420132012201120102009200820072006
Omzet 1,375,328.7451,280,091.8511,152,975.6981,055,423.691,113,425.9211,031,427.426960,307.423883,920.425839,686.478735,889.424682,508.016669,013.833710,547.146509,993.136613,750.337548,326.626484,346.075400,443.393
Kosten van de omzet 688,220.996641,134.291608,229.804608,481.968635,132.494621,484.738553,325.208510,232.177537,082.983465,702.015390,805.395391,898.198409,830.898285,540.515322,037.706294,324.505223,960.069179,564.233
Brutowinst 687,107.749638,957.56544,745.895446,941.722478,293.427409,942.687406,982.215373,688.247302,603.495270,187.409291,702.621277,115.635300,716.249224,452.621291,712.631254,002.121260,386.006220,879.16
Brutowinstmarge 0.50.4990.4720.4230.430.3970.4240.4230.360.3670.4270.4140.4230.440.4750.4630.5380.552
Onderzoek- en ontwikkelingskosten 171,573.444163,601.58127,269.068115,217.59109,440.5113,811.779107,938.832103,691.02231,068.17818,742.57421,169.52219,643.10619,519.5694,311.70910,298.1123,271.5347,071.9615,828.152
Algemene en administratieve kosten 14,188.73120,411.32719,145.98519,046.66224,210.7626,999.88426,480.21228,750.86426,373.30625,559.4628,206.17124,932.30426,423.09916,569.41335,138.44942,400.74130,853.76526,779.947
Verkoop- en marketingkosten 211,163.121225,004.92196,054.443188,701.171191,033.099140,898.581118,654.377102,841.43793,641.66582,282.24574,327.87587,770.42690,827.67267,143.31687,217.86381,260.09875,889.75763,493.47
Verkoop-, algemene en administratieve kosten 383,418.016245,416.247215,200.428207,747.833215,243.859167,898.465145,134.589131,592.301120,014.971107,841.705102,534.046112,702.73117,250.77183,712.729122,356.312123,660.839106,743.52290,273.417
Overige kosten 0134,142.584113,374.222106,996.574108,921.9713,637.0738,849.8294,509.5723,302.861989.8094,613.2674,517.7741,605.581-6,717.2916,367.7045,202.7022,864.365-6,362.229
Bedrijfskosten 474,806.33543,160.411455,843.718429,961.997433,606.33385,376.52368,025.066347,794.762259,039.05218,243.015220,330.988240,232.815238,791.551153,214.147217,011.452212,021.513186,986.338150,593.708
Bedrijfsresultaat 133,406.75257,099.65727,606.07816,979.72444,687.09724,566.16838,957.14925,893.48543,564.44551,944.39471,371.63336,882.81963,630.24671,238.47774,701.17941,980.60573,399.66470,285.454
Bedrijfsresultaat ratio 0.0970.0450.0240.0160.040.0240.0410.0290.0520.0710.1050.0550.090.140.1220.0770.1520.176
Totaal overige inkomsten en kosten netto -21,775.509-18,770-7,844.712-14,257.958-21,365.424-28,218.728-15,199.547-10,948.372-6,763.592-3,937.51-5,039.4954,842.353344.428-4,148.538-3,422.6052,401.5296,175.66-2,574.232
Inkomen voor belasting 111,631.24338,329.65719,934.22213,559.33323,321.673-622.52236,132.50827,609.29447,751.42353,684.99674,002.60141,725.17263,974.67467,089.93971,278.57444,382.13479,575.32467,711.222
Inkomen voor belasting ratio 0.0810.030.0170.0130.021-0.0010.0380.0310.0570.0730.1080.0620.090.1320.1160.0810.1640.169
Belastingkosten 129.444-833.512-10,322.78-10,588.733-5,543.93314,794.722696.1711,483.42312,077.72223,215.0416,028.28,212.30913,246.56949,527.1121,811.56611,656.79820,749.29419,188.168
Nettowinst 111,501.79942,239.51824,505.73624,148.06622,005.927-15,151.84831,580.58426,969.82142,930.0631,544.47558,399.56534,079.29450,185.94617,562.8349,467.00832,930.96358,948.24548,523.054
Nettowinstmarge 0.0810.0330.0210.0230.02-0.0150.0330.0310.0510.0430.0860.0510.0710.0340.0810.060.1220.121
WPA (Winst Per Aandeel) 10,6563,815.952,226.872,264.772,132.18-1,468.083,0602,6134,1603,0565,6583,3024,998.061,677.824,663.563,064.395,411.144,433.64
Verwaterde WPA 10,6563,815.952,226.872,264.772,132.18-1,4683,0602,6134,1603,0565,6583,3024,998.061,677.824,663.563,064.395,411.144,433.64
EBITDA 164,914.59985,123.12469,072.22962,935.35872,054.55258,957.3483,194.20559,003.86173,127.05767,133.31389,548.34260,415.03183,311.72281,124.97990,668.07160,928.12387,425.72678,838.72
EBITDA ratio 0.120.0760.0590.0580.0760.080.0910.0690.0890.10.1420.0940.1240.1570.1850.0730.1810.195